Search
forLearn
5 / 801 resultslearn Haritaki
learn Tumeric
learn Curcumin
learn Cepharanthine
Research
5 / 1000+ results
research Management of Alopecia Areata Through Micro Needling Along with Cupping
An 18-year-old with hair loss saw hair regrowth after treatments combining microneedling, cupping, medication, and oil application.
research Ayurvedic approach for managing Indralupta (Alopecia Areata): A Case Study
Ayurvedic treatment effectively cured a boy's alopecia areata with no side effects or recurrence.
research EVALUATION OF THE EFFECTIVENESS OF AMRABIJA CHURNAM AND HARITAKI CHURNAM (EXTERNAL APPLICATION) IN THE MANAGEMENT OF DARUNAKA (DANDRUFF): A CASE STUDY
The Ayurvedic paste effectively relieved dandruff symptoms in a 14-year-old boy.
research "A literature review on “Triphala’s Rasayana Karmukata."
Triphala is a safe herbal remedy that aids digestion, cleanses the colon, boosts immunity, and may have anti-cancer benefits.
research Pica for Uncooked Basmati Rice in Two Women with Iron Deficiency and a Review of Ryzophagia
Iron therapy resolved uncooked rice cravings and symptoms in women with iron deficiency.
Community Join
5 / 1000+ resultscommunity Kintor Phase 2 Results released KX-826 (pyrilutamide)
Kintor Pharmaceutical's Phase 2 results with the drug Pyrilutamide, a potential alternative to 5-ARI drugs like Finasteride and Dutasteride but without the side effects. It could be used in combination with other topical treatments such as Minoxidil. The safety of the drug has been demonstrated in 6 months of use, however there are still questions about long term efficacy and systemic absorption.
community Kintor has released an investor relations memo regarding Chinese Phase III trials for Pyrilutamide
Kintor's Pyrilutamide (KX-826) showed hair growth in Chinese Phase III trials but did not significantly outperform placebo. The treatment was safe with no major adverse reactions reported.
community When will Breezula be released and how does it compare to KX-826?
Breezula (clascoterone) is expected to be available by late 2026, showing good long-term results with minimal side effects. KX-826 (pyrilutamide) acts faster but is still in earlier development stages.
community Kintor KX -826 Pyrilutamide Adds 1 Year Phase 3 Trial For Safety
KX-826/pyrilutamide is undergoing an additional one-year safety and efficacy trial in China after a six-month study. Some participants speculate on the reasons for the extended trial and discuss the potential of other treatments.
community PG causing irritation when applying RU
The user is experiencing irritation from using PG with RU58841 and is seeking alternative solutions like K&B in the UK. They report redness, itchiness, and flaky skin from the current treatment.